Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2017-05-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Performance of a New Reduced Noise Mask Vent
NCT01575210
The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)
NCT02730273
Sleep Apnea Treatment With Expiratory Resistance(Provent™)
NCT01061476
Assessment of Circuit Rebreathing During CPAP Therapy
NCT07062770
Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of OSA Syndrome
NCT04925739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Washing procedure 1
this group will apply washing technique 1
CPAP mask
A new vent CPAP mask system will be used in this trial
Washing procedure 2
this group will apply washing technique 2
CPAP mask
A new vent CPAP mask system will be used in this trial
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CPAP mask
A new vent CPAP mask system will be used in this trial
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants who can read and comprehend English
* Participants using APAP for \>6 months
* Participants who are willing to use the mask system for the 3 month duration of the trial.
* Participants who are over 18 years of age
* Participants who currently use a nasal mask system
Exclusion Criteria
* Participants who cannot read and comprehend English
* Participants using an inappropriate mask system
* Participants on a Bilevel or ASV therapy
* Participants who are pregnant
* Participants with a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer lung injury; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection
* Participants or whose bed partner with implantable metallic implants in the head, neck and chest region affected by magmetic fields (Non-ferrous implants may be acceptable)
* Participants that weight \<30 kg
* Participants who are unsuitable to participate in the study in the opinion of the researcher
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ResMed
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klaus Schindhelm, PhD
Role: PRINCIPAL_INVESTIGATOR
ResMed/The University of New South Wales
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MA300516
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.